Cari Health

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Cari Health sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 1 completed upper quartile by trial count

Cari Health: 3 sponsored US clinical trials, 1 recruiting.

Cari Health sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Metabolism Medication Toxicity, with 1 trials.

Upper-quartile sponsor footprint

Cari Health sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

Assessment of Methadone Dose Taken

NCT05981573
NOT YET RECRUITING

Methadone Dose Monitoring With a Remote Medication Monitor

NCT06837571
COMPLETED

Assessment of Methadone and Buprenorphine in Interstitial Fluid

NCT05546229

Therapeutic Areas

Metabolism Medication Toxicity 1
Methadone Overdose 1
Methadone Toxicity 1
Drug Metabolism, Poor, CYP2D6-Related 1
Pain, Chronic 1
Opioid Use Disorder 1

What is open in the Cari Health pipeline

1 recruiting of 3 indexed (33% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Metabolism Medication Toxicity (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Cari Health: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Cari Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Cari Health10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Cari Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cari Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Cari Health page

3 registered trials is a research-attention snapshot, not an endorsement of Cari Health or any single study.

  • 1 of Cari Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Metabolism Medication Toxicity is the condition Cari Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Metabolism Medication Toxicity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cari Health pipeline card: 3 registered trials from official public datasets.Report a data error.